Skip to main content
SpringerLink
Log in

Inhibition of osteosarcoma growth and metastasis using a polysaccharide derivative of Amy-g-PLLD for the delivery of AEG-1 siRNA

  • Research Article
  • Published:
Nano Research Aims and scope Submit manuscript

Abstract

Osteosarcoma is the most common primary malignant neoplasm of the bone in children and adolescents and has a high risk of relapse and metastasis. Of the various methods to treat osteosarcoma, the use of genetic approaches to inhibit the rapid growth of osteosarcoma while limiting tumor metastasis has presented a challenge in its implementation. Here, we successfully synthesized a polysaccharide derivative (Amy-g-PLLD) for delivery of astrocyte elevated gene-1 (AEG-1) small-interfering RNA (siRNA) (siAEG-1), and used it for the first time to suppress osteosarcoma tumors in vitro and in vivo. Amy-g-PLLD/ siAEG-1 complexes were delivered into 143B human osteosarcoma cells with low resultant cytotoxicity. Osteosarcoma tumor proliferation and invasion were inhibited in vitro. Intratumoral injection of Amy-g-PLLD/siAEG-1 complexes markedly inhibited tumor growth and lung metastasis in 143B tumor-bearing mice. This biocompatible and effective approach employing a natural material-siRNA complex should pave the way for more genetic research in treating osteosarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mirabello, L.; Troisi, R. J.; Savage, S. A. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer 2009, 115, 1531–1543.

    Article  Google Scholar 

  2. Stiller, C. A.; Bielack, S. S.; Jundt, G.; Steliarova-Foucher, E. Bone tumours in European children and adolescents, 1978–1997. Report from the automated childhood cancer information system project. Eur. J. Cancer 2006, 42, 2124–2135.

    Google Scholar 

  3. Bacci, G.; Briccoli, A.; Ferrari, S.; Saeter, G.; Donati, D.; Longhi, A.; Manfrini, M.; Bertoni, F.; Rimondini, S.; Monti, C. et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: Treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide. Oncol. Rep. 2000, 7, 339–385.

    Google Scholar 

  4. Su, Z. Z.; Kang, D. C.; Chen, Y. M.; Pekarskaya, O.; Chao, W.; Volsky, D. J.; Fisher, P. B. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 2002, 21, 3592–3602.

    Article  Google Scholar 

  5. Yoo, B. K.; Emdad, L.; Su, Z. Z.; Villanueva, A.; Chiang, D. Y.; Mukhopadhyay, N. D.; Mills, A. S.; Waxman, S.; Fisher, R. A.; Llovet, J. M. et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J. Clin. Invest. 2009, 119, 465–477.

    Article  Google Scholar 

  6. Wang, F.; Ke, Z. F.; Sun, S. J.; Chen, W. F.; Yang, S. C.; Li, S. H.; Mao, X. P.; Wang, L. T. Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis. Cancer Biol. Ther. 2011, 12, 539–548.

    Article  Google Scholar 

  7. Sledz, C. A.; Williams, B. R. G. RNA interference in biology and disease. Blood 2005, 106, 787–794.

    Article  Google Scholar 

  8. Anderson, W. F. Human gene therapy. Nature 1998, 392, 25–30.

    Article  Google Scholar 

  9. Li, W. J.; Szoka, F. C. Jr. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 2007, 24, 438–449.

    Google Scholar 

  10. Daka, A.; Peer, D. RNAi-based nanomedicines for targeted personalized therapy. Adv. Drug Deliv. Rev. 2012, 64, 1508–1521.

    Article  Google Scholar 

  11. Peer, D. Harnessing RNAi nanomedicine for precision therapy. Mol. Cell Ther. 2014, 2, 5.

    Article  Google Scholar 

  12. Tian, H. Y.; Chen, J.; Chen, X. S. Nanoparticles for gene delivery. Small 2013, 9, 2034–2044.

    Article  Google Scholar 

  13. Williford, J. M.; Wu, J.; Ren, Y.; Archang, M. M.; Leong, K. W.; Mao, H. Q. Recent advances in nanoparticlemediated siRNA delivery. Annu. Rev. Biomed. Eng. 2014, 16, 347–370.

    Article  Google Scholar 

  14. Semple, S. C.; Akinc, A.; Chen, J. X.; Sandhu, A. P.; Mui, B. L.; Cho, C. K.; Sah, D. W.; Stebbing, D.; Crosley, E. J.; Yaworski, E. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 2010, 28, 172–176.

    Article  Google Scholar 

  15. Sato, Y.; Hatakeyama, H.; Sakurai, Y.; Hyodo, M.; Akita, H.; Harashima, H. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo. J. Control. Release 2012, 163, 267–276.

    Article  Google Scholar 

  16. Elbakry, A.; Zaky, A.; Liebl, R.; Rachel, R.; Goepferich, A.; Breunig, M. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett. 2009, 9, 2059–2064.

    Article  Google Scholar 

  17. Lei, Y. F.; Tang, L. X.; Xie, Y. Z. Y.; Xianyu, Y. L.; Zhang, L. M.; Wang, P.; Hamada, Y.; Jiang, K.; Zheng, W. F.; Jiang, X. Y. Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer. Nat. Commun. 2017, 8, 15130.

    Article  Google Scholar 

  18. Xiao, Y. L.; Jaskula-Sztul, R.; Javadi, A.; Xu, W. J.; Eide, J.; Dammalapati, A.; Kunnimalaiyaan, M.; Chen, H.; Gong, S. Q. Co-delivery of doxorubicin and siRNA using octreotideconjugated gold nanorods for targeted neuroendocrine cancer therapy. Nanoscale 2012, 4, 7185–7193.

    Article  Google Scholar 

  19. Sun, C. Y.; Shen, S.; Xu, C. F.; Li, H. J.; Liu, Y.; Cao, Z. T.; Yang, X. Z.; Xia, J. X.; Wang, J. Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery. J. Am. Chem. Soc. 2015, 137, 15217–15224.

    Article  Google Scholar 

  20. Cai, X. J.; Zhu, H. F.; Zhang, Y. M.; Gu, Z. W. Highly efficient and safe delivery of VEGF siRNA by bioreducible fluorinated peptide dendrimers for cancer therapy. ACS Appl. Mater. Interfaces 2017, 9, 9402–9415.

    Article  Google Scholar 

  21. Zhang, N.; Chen, H.; Liu, A. Y.; Shen, J. J.; Shah, V.; Zhang, C.; Hong, J.; Ding, Y. Gold conjugate-based liposomes with hybrid cluster bomb structure for liver cancer therapy. Biomaterials 2016, 74, 280–291.

    Article  Google Scholar 

  22. Zhao, X.; Li, F.; Li, Y. Y.; Wang, H.; Ren, H.; Chen, J.; Nie, G. J.; Hao, J. H. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Biomaterials 2015, 46, 13–25.

    Article  Google Scholar 

  23. Lee, J. M.; Yoon, T. J.; Cho, Y. S. Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed. Res. Int. 2013, 2013, 782041.

    Google Scholar 

  24. Singha, K.; Namgung, R.; Kim, W. J. Polymers in smallinterfering RNA delivery. Nucl. Acid Ther. 2011, 21, 133–147.

    Article  Google Scholar 

  25. Merdan, T.; Kopecek, J.; Kissel, T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev. 2002, 54, 715–758.

    Article  Google Scholar 

  26. Miyata, K.; Kakizawa, Y.; Nishiyama, N.; Yamasaki, Y.; Watanabe, T.; Kohara, M.; Kataoka, K. Freeze-dried formulations for in vivo gene delivery of PEGylated polyplex micelles with disulfide crosslinked cores to the liver. J. Control. Release 2005, 109, 15–23.

    Article  Google Scholar 

  27. Sun, P.; Huang, W.; Jin, M.; Wang, Q.; Fan, B.; Kang, L.; Gao, Z. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis. Int. J. Nanomed. 2016, 11, 4931–4945.

    Article  Google Scholar 

  28. Cai, X.; Yang, L. Q.; Huang, Y. F.; Peng, N. F.; Zhang, L. M.; Wu, Q.; Chen, R. F. Targeted and controlled release of indomethacin from a prodrug of amylose. In Proceedings of the 7th Asian-Pacific Conference on Medical and Biological Engineering, Berlin, Heidelberg, 2008, pp 29–31.

    Chapter  Google Scholar 

  29. Gao, W.; Sha, B. Y.; Zou, W.; Liang, X.; Meng, X. Z.; Xu, H.; Tang, J.; Wu, D. C.; Xu, L. X.; Zhang, H. Cationic amylose-encapsulated bovine hemoglobin as a nanosized oxygen carrier. Biomaterials 2011, 32, 9425–9433.

    Article  Google Scholar 

  30. Moghadam, S. H.; Wang, H. W.; Saddar El-Leithy, E.; Chebli, C.; Cartilier, L. Substituted amylose matrices for oral drug delivery. Biomed. Mater. 2007, 2, S71–S77.

    Article  Google Scholar 

  31. Qiu, C.; Qin, Y.; Zhang, S. L.; Xiong, L.; Sun, Q. J. A comparative study of size-controlled worm-like amylopectin nanoparticles and spherical amylose nanoparticles: Their characteristics and the adsorption properties of polyphenols. Food Chem. 2016, 213, 579–587.

    Article  Google Scholar 

  32. Pahimanolis, N.; Sorvari, A.; Luong, N. D.; Seppälä, J. Thermoresponsive xylan hydrogels via copper-catalyzed azide-alkyne cycloaddition. Carbohydr. Polym. 2014, 102, 637–644.

    Article  Google Scholar 

  33. Ma, D.; Zhang, H. B.; Chen, Y. Y.; Lin, J. T.; Zhang, L. M. New cyclodextrin derivative containing poly(L-lysine) dendrons for gene and drug co-delivery. J. Colloid Interface Sci. 2013, 405, 305–311.

    Article  Google Scholar 

  34. Pang, J. D.; Zhuang, B. X.; Mai, K. J.; Chen, R. F.; Wang, J.; Zhang, L. M. Click modification of helical amylose by poly(L-lysine) dendrons for non-viral gene delivery. Mater. Sci. Eng. C 2015, 49, 485–492.

    Article  Google Scholar 

  35. Wang, F.; Ke, Z. F.; Wang, R.; Wang, Y. F.; Huang, L. L.; Wang, L. T. Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway. Biochem. Biophys. Res. Common. 2014, 452, 933–939.

    Article  Google Scholar 

  36. Yu, C. P.; Chen, K.; Zheng, H. Q.; Guo, X. Z.; Jia, W. H.; Li, M. Z.; Zeng, M. S.; Li, J.; Song, L. B. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009, 30, 894–901.

    Article  Google Scholar 

  37. Emdad, L.; Sarkar, D.; Su, Z. Z.; Randolph, A.; Boukerche, H.; Valerie, K.; Fisher, P. B. Activation of the nuclear factor ?B pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis. Cancer Res. 2006, 66, 1509–1516.

    Article  Google Scholar 

  38. Yoo, B. K.; Emdad, L.; Su, Z. Z.; Villanueva, A.; Chiang, D. Y.; Mukhopadhyay, N. D.; Mills, A. S.; Waxman, S.; Fisher, R. A.; Llovet, J. M. et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J. Clin. Invest. 2009, 119, 465–477.

    Article  Google Scholar 

  39. Kawata, E.; Ashihara, E.; Kimura, S.; Takenaka, K.; Sato, K.; Tanaka, R.; Yokota, A.; Kamitsuji, Y.; Takeuchi, M.; Kuroda, J. et al. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer. Mol. Cancer Ther. 2008, 7, 2904–2912.

    Article  Google Scholar 

  40. Huh, M. S.; Lee, E. J.; Koo, H.; Yhee, J. Y.; Oh, K. S.; Son, S.; Lee, S.; Kim, S. H.; Kwon, I. C.; Kim, K. Polysaccharidebased nanoparticles for gene delivery. Topics Curr. Chem. 2017, 375, 31.

    Article  Google Scholar 

  41. Raemdonck, K.; Martens, T. F.; Braeckmans, K.; Demeester, J.; De Smedt, S. C. Polysaccharide-based nucleic acid nanoformulations. Adv. Drug Deliv. Rev. 2013, 65, 1123–1147.

    Article  Google Scholar 

  42. Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Sizedependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 2004, 377, 159–169.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Nos. 81402221 and 51273216), the Research Fund for the Doctoral Program of Higher Education of China (No. 20130171120077), the Science and Technology Program of Guangzhou, China (No. 201707010108), the Guangdong Innovative Research Team Program (No. 2009010057), and the Science and Technology Planning Project of Guangzhou (No. 201610010006), the Science and Technology Planning project of Guangdong Province (No. 20153900042020319) and Natural Science Foundation of Guangdong Province (No. 2016A030313819).

Author information

Author notes

  1. Fen Wang and Jiadong Pang contributed equally to this work.

Authors and Affiliations

  1. Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China

    Fen Wang, Leilei Huang & Ran Wang

  2. PCFM Lab and GDHPPC Lab, School of Materials Science and Engineering, Sun Yat-sen University, Guangzhou, 510275, China

    Jiadong Pang & Liming Zhang

  3. School of Engineering, Sun Yat-sen University, Guangzhou, 510006, China

    Qing Jiang & Kang Sun

  4. School Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instruments, Sun Yat-sen University, Guangzhou, 510006, China

    Qing Jiang & Kang Sun

Authors
  1. Fen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiadong Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leilei Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ran Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qing Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liming Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Liming Zhang or Kang Sun.

Electronic supplementary material

12274_2018_1965_MOESM1_ESM.pdf

Inhibition of osteosarcoma growth and metastasis using a polysaccharide derivative of Amy-g-PLLD for the delivery of AEG-1 siRNA

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, F., Pang, J., Huang, L. et al. Inhibition of osteosarcoma growth and metastasis using a polysaccharide derivative of Amy-g-PLLD for the delivery of AEG-1 siRNA. Nano Res. 11, 3886–3898 (2018). https://doi.org/10.1007/s12274-018-1965-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12274-018-1965-4

Keywords

Search

Navigation